Zolinza 100 MG Oral Capsule

RxCUI: 668606
RxNorm name: Zolinza 100 MG Oral Capsule
Display name: Zolinza 100 MG Oral Capsule
Full name: Zolinza 100 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZOLINZA	VORINOSTAT	Merck Sharp & Dohme LLC	cd86ee78-2781-468b-930c-3c4677bcc092	2024-11-12	Warnings, Adverse reactions	Exact identifier rxcui: 668606

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
cd86ee78-2781-468b-930c-3c4677bcc092	Zolinza 100 MG Oral Capsule	PSN	27	These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA ® (vorinostat capsules, for oral use) Initial U.S. Approval: 2006	20241112
cd86ee78-2781-468b-930c-3c4677bcc092	Zolinza 100 MG Oral Capsule	SY	27	These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA ® (vorinostat capsules, for oral use) Initial U.S. Approval: 2006	20241112
cd86ee78-2781-468b-930c-3c4677bcc092	vorinostat 100 MG Oral Capsule [Zolinza]	SBD	27	These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA ® (vorinostat capsules, for oral use) Initial U.S. Approval: 2006	20241112